Clinical Trials on Idiopathic Pulmonary Fibrosis
Total 14659 results
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, Israel, Spain, Australia, France, Canada, Turkey, Germany, Italy, South Africa, Slovenia, Sweden
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Institut National de la Santé Et de la Recherche...CompletedIdiopathic Pulmonary Fibrosis
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Switzerland, Israel, Canada, France, Germany, Italy
-
Rabin Medical CenterUnknownIdiopathic Pulmonary FibrosisIsrael
-
InterMuneCompletedIdiopathic Pulmonary FibrosisUnited States
-
Cedars-Sinai Medical CenterGenentech, Inc.Recruiting
-
Blade TherapeuticsNot yet recruitingRESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis
-
University Hospital, ToursInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingIdiopathic Pulmonary FibrosisFrance
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, Germany, Italy, Canada, Ireland, United Kingdom
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisGreece
-
Assistance Publique - Hôpitaux de ParisCompletedIdiopathic Pulmonary FibrosisFrance
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Italy, Germany, Switzerland, Czechia, Spain
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Belgium, Australia, United Kingdom, Canada, China, Germany, Japan, Turkey, France, Ireland, Italy, Israel, Netherlands, Portugal, Greece, India, Czechia, Chile, Finland, Mexico, Russian Federation
-
Belgian Thoracic SocietyBoehringer Ingelheim; Roche Farma, S.ACompletedIdiopathic Pulmonary FibrosisBelgium, Luxembourg
-
Institut d'Investigació Biomèdica de BellvitgeCompleted
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
University Hospital, ToursCompletedIdiopathic Pulmonary FibrosisFrance
-
Steward St. Elizabeth's Medical Center of Boston...Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
The University of Hong KongQueen Mary Hospital, Hong KongTerminatedIdiopathic Pulmonary FibrosisHong Kong
-
Royal Brompton & Harefield NHS Foundation TrustKings Clinical Trials UnitCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of PittsburghNational Institute of Nursing Research (NINR)CompletedIdiopathic Pulmonary FibrosisUnited States
-
Istanbul University-CerrahpasaUnknownIdiopathic Pulmonary FibrosisTurkey
-
Medical College of WisconsinTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Afferent Pharmaceuticals, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Canada, Belgium, Australia, United Kingdom, Germany, Italy, France, Japan, Mexico, India
-
George Papanicolaou HospitalUnknown
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Turkey
-
NYU Langone HealthWithdrawnIdiopathic Pulmonary FibrosisUnited States
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Genentech, Inc.Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Canada, Chile, China, Finland, France, Germany, Greece, India, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, Spain, Turkey
-
The Prince Charles HospitalMater Medical Research InstituteCompletedIdiopathic Pulmonary FibrosisAustralia
-
Centocor, Inc.CompletedPulmonary FibrosisUnited States, Canada, Netherlands, Belgium, Germany
-
University of MichiganNational Institutes of Health (NIH)CompletedIdiopathic Pulmonary FibrosisUnited States
-
University of California, San FranciscoCompleted
-
Gilead SciencesCompletedIdiopathic Pulmonary FibrosisUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Zambon SpACompletedPulmonary FibrosisSpain, Germany, Belgium, France, Italy, Netherlands, United Kingdom
-
Boehringer IngelheimCompleted
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNanjing Chia-tai Tianqing PharmaceuticalCompletedIdiopathic Pulmonary Fibrosis
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
CelgeneTerminatedPathologic Processes | Fibrosis | Respiratory Tract Diseases | Lung Diseases | Idiopathic Pulmonary Fibrosis | Lung Diseases, Interstitial | Idiopathic Interstitial PneumoniasUnited States, Australia, Colombia, United Kingdom, Russian Federation, Brazil, Germany, Canada, Greece, Romania, Taiwan, Turkey, Ukraine
-
Assiut UniversityNot yet recruitingIdiopathic Pulmonary FibrosisEgypt
-
Guangdong Hengrui Pharmaceutical Co., LtdRecruitingIdiopathic Pulmonary FibrosisChina
-
Groupe Hospitalier Paris Saint JosephRecruitingIdiopathic Pulmonary FibrosisFrance
-
University of WashingtonGenentech, Inc.Recruiting
-
Henan University of Traditional Chinese MedicineRecruiting
-
Hal ChapmanNational Heart, Lung, and Blood Institute (NHLBI)CompletedIdiopathic Pulmonary FibrosisUnited States